The invivosystem with Aether Fusion Collects Real-Time Patient Experience Data.Business Editors/High-Tech Writers Synchronization (1) See synchronous and synchronous transmission. (2) Ensuring that two sets of data are always the same. See data synchronization. (3) Keeping time-of-day clocks in two devices set to the same time. See NTP. And Device Management Components of Aether aether: see ether, in physics and astronomy. Aether god of whole atmosphere. [Gk. Myth.: Jobes, 42] See : Air Fusion(TM)Integrated Into invivodata's Electronic Diary Solution Aether Systems, Inc. (Nasdaq:AETH), a leading provider of wireless and mobile data solutions, today announced that invivodata(R), inc. a data solutions provider for the pharmaceutical industry, has successfully integrated and deployed synchronization and device management components of Aether Fusion,(TM) Aether's wireless technology foundation. Aether's technology helps the Scotts Valley, Calif.-based company deliver the invivosystem(TM), an electronic diary solution to collect real-time, patient self-report data in clinical trials. The invivosystem electronic patient diaries A Patient Diary is a tool used during a clinical trial or a disease treatment to measure treatment compliance. An Electronic Patient Diary registers the diary in a storage device and allows for monitoring the time the medication was taken. provide more accurate and sensitive tests of medication effects than currently prevalent paper-based diaries. Using a Palm(R) OS device, invivosystem users taking part in a clinical trial can record critical study data consistent with the clinical trial protocol A Clinical Trial Protocol is a document that describes the objective(s), design, methodology, statistical considerations, and organization of a clinical trial. The protocol usually also gives the background and reason the trial is being conducted, but these could be provided in . By pointing and tapping on the Palm device screen, patients easily record their experiences, including how they respond to new treatments, what symptoms they are experiencing, and their general well being. A variety of methods, such as a friendly "beep," remind patients to enter data according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the study protocol. Aether's wireless technology foundation enables invivosystem users to upload patient-entered data several ways: immediately, by using a wireless connection; daily, from the patient's home telephone connection; or at the research site during a patient's regular visit. Aether's device management solution enables administrators to actively manage and monitor the devices and mobile applications in use during the trial. invivodata's mobile diary addresses the challenges associated with paper-based data collection systems, including inaccurate data entry, transcription errors A transcription error is a specific type of data entry error that is commonly made by human operators or by optical character recognition programs (OCR). Human transcription errors are commonly the result of typographical mistakes, putting fingers in the wrong place during touch made while copying paper thin unsized paper used for taking copies of letters, etc., in a copying press. See also: Copying diaries into an online database, and non-compliance by patients - i.e., patients neglecting to make diary entries in real-time and back-filling a week's worth of diary entries before seeing the doctor. "Integrating our electronic diary with Aether's sync technology allows us to provide a comprehensive offering to pharmaceutical companies," said Jon McClelland, Vice President, Product Development, invivodata, inc. "It gives them immediate access to reliable and valid patient data." "invivodata has developed a mobile data solution that allows sponsors of clinical trials to record more reliable data on a patient's experience -- information that is critical when determining the effectiveness of a new drug," said Brian Keane, President, Enterprise Solutions Division, Aether Systems. "This application is a great example of how mobile solutions can increase the integrity and effectiveness of data collection, even for the most sensitive initiatives." invivodata launched invivosystem with Aether Fusion in the second half of 2001. Since its launch, the robustness of the integrated system has been proven through use within nearly 20 clinical trials, including on-going trials being conducted by Cypress Bioscience, Otsuka Maryland Research Institute, and Amylin Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. Currently, Amylin produces two drugs, Symlin (pramlintide acetate) and Byetta (exenatide). Amylin also is working on producing a drug based on Leptin. . About Aether Systems Inc. Aether Systems delivers wireless and mobile data solutions that make people more productive and their organizations more profitable. Aether's products and services are built on Aether Fusion, the company's standards-based platform that allows for secure, reliable extension of critical information to virtually any wireless or mobile environment. Return on investment in Aether solutions comes from a unique combination of strengths - quick access to multiple back-end information sources, workflow that is optimized for specific industries, and turnkey deployment services and professional support. Backed by years of in-market expertise, Aether is making it possible for thousands of businesses and government agencies to unleash the power of the mobile workforce. For more information, please visit www.aethersystems.com. About invivodata invivodata (www.invivodata.com) uniquely combines behavioral science behavioral science n. A scientific discipline, such as sociology, anthropology, or psychology, in which the actions and reactions of humans and animals are studied through observational and experimental methods. , technology, and clinical expertise to capture clinical trial data of the highest-possible integrity directly from patients. Far superior to paper diary methods, invivodata's electronic patient diary solution, the invivosystem, delivers more reliable and valid data than any other diary method by driving patient compliance with the protocol and eliminating recall biases that plague self-report studies. The invivodata solution provides real-time access to study data, giving study researchers and sponsors visibility into study progress and improving study efficiencies. The invivosystem was developed and validated according to a rigorous Computer System Validation policy based A decision made by any software application that is based on the policy (rules and regulations) of the organization. See policy and COPS. on 21 CFR CFR See: Cost and Freight Part 11. It has been used in over 45 studies involving thousands of patients. Having collected over 1,500,000 patient-initiated records, invivodata's solution is mature and market-proven. No other electronic diary solution has processed more patient records than the invivosystem. invivodata, inc., a privately-held company, is headquartered in Scotts Valley, California Scotts Valley is a small city located in eastern Santa Cruz County, California, United States, about ten miles (16 km) south of San Jose and six miles (10 km) north of the beach in the upland slope of the Santa Cruz Mountains. As of the 2000 census, the city population was 11,385. . The clinical trial operation center is located in Pittsburgh, Pennsylvania “Pittsburgh” redirects here. For the region, see Pittsburgh Metropolitan Area. Pittsburgh (pronounced IPA: /ˈpɪtsbɚg/) is the second largest city in the Commonwealth of Pennsylvania. . This press release includes forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. based on current expectations and projections about future events. These forward-looking statements are subject to a number of risks, uncertainties and assumptions about Aether that could cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, but are not limited to, the ability of Aether and invivodata to successfully develop the products and services described in this release. These risks and other risk factors are described in Aether's report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. with respect to the fiscal year ending December 31, 2000 and other documents filed with the Securities and Exchange Commission. Aether undertakes no obligation to update the forward-looking statements contained in this press release. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion